Article thumbnail

Cardiorenal Syndrome: An Unsolved Clinical Problem

By Paula Martínez-Santos and Isidre Vilacosta


The clinical relevance of the bidirectional cross-talk between heart and kidney is increasingly recognized. However, the optimal approach to the management of kidney dysfunction in heart failure remains unclear. The purpose of this article is to outline the most plausible pathophysiologic theories that attempt to explain the renal impairment in acute and chronic heart failure, and to review the current treatment strategies for these situations

Topics: Review Article
Publisher: SAGE-Hindawi Access to Research
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. and P.A.Sobotka,“Ultrafiltrationisassociatedwithfewerrehospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOAD,”
  2. (2009). Anemia: the point of convergence or divergence for kidney disease and heart failure?”
  3. (2010). Aspromonte et al., “Epidemiology of cardio-renal syndromes: workgroup statements from
  4. (2002). Baseline hematocrit predicts clinical outcomes in heart failure,”
  5. (2010). Biomarkers of cardiac and kidney dysfunction in cardiorenal syndromes,”
  6. (2006). C o wi e ,M .K o m a j d a ,T .M u rr a y - T h o m a s ,J .U n d e rw o o d
  7. (2007). Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007. Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers,”
  8. (2010). Cardiorenal syndrome in decompensated heart failure,”
  9. (2010). Cardiorenal syndrome: new perspectives,”
  10. (2010). Congestion as a therapeutic target in acute heart failure syndromes,”
  11. (2000). Correlates and impact on outcomes of worsening renal function in patients ≥65 years of age with heart failure,”
  12. (2003). Diuretic use, progressive heart failure, and death in patients in
  13. (2009). Dual blockade of the reninangiotensin system for cardiorenal protection: an update,”
  14. (2008). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure
  15. (2010). H e y w o o d ,G .C .F o n a r o w ,C .W .Y a n c ye ta l . ,“ I n fl u e n c eo f renalfunctionontheuseofguideline-recommendedtherapies forpatientswithheartfailure,”AmericanJournalofCardiology,
  16. (2007). H e y w o o d ,G .C .F o n a r o w ,M .R .C o s t a n z o ,V .S .M a t h u r
  17. (2003). H.Reinecke,T.Trey,J.Wellmannetal.,“Haemoglobin-related mortality in patients undergoing percutaneous coronary interventions,”
  18. (2004). Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial,”
  19. (2009). Importance of venous congestion for worsening of renal function in advanced decompensated heart failure,”
  20. (2006). Kidney function and mortality among patients with left ventricular systolic dysfunction,”
  21. (2007). Lung, and Blood Institute Working Group, Cardiorenal Connections
  22. (2008). o n c o ,M .H a a p i o ,A .A .H o u s e ,N .A n a v e k a r ,a n dR .
  23. Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure,”
  24. (2008). Prompt reduction in intraabdominal pressure following large-volume mechanical fluid removal improves renal insufficiency in refractory decompensated heart failure,”
  25. (1998). Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema,”
  26. (2001). Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction,” J o u r n a lo ft h e
  27. (2007). Relation between dose of loop diuretics and outcomes in a heart failure population:
  28. (2004). Renal function, digoxin therapy, and heart failure outcomes: evidence from the digoxin intervention group trial,”
  29. (2000). Renal function, neurohormonal activation, and survival in patients with chronic heart failure,”
  30. (2008). Skouri et al., “Elevated intraabdominal pressure in acute decompensated heart failure. A potential contributor to worsening renal function?”
  31. Testing the Effectiveness ofNesiritide inPatients With Acute Decompensated Heart Failure,
  32. (2010). The Diuretic Optimization Strategies Evaluation (DOSE) Study: a Randomized, Double Blind, Placebo-controlled Trial Of Diuretic Strategies In Acute Decompensated Heart Failure,
  33. (2002). The prognostic importance of different definitions of worsening renal function in congestive heart failure,”Journalof CardiacFailure,vol.
  34. (2005). The severe cardiorenal syndrome: “Guyton revisited”,”
  35. (2008). Transient worsening of renal function during hospitalization for acute heart failure alters outcome,”
  36. (2007). Udelson et al., “Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist
  37. (2007). venous congestion and the association with renal impairment in patients with cardiac dysfunction,”
  38. (2008). Worsening renal functioninpatientshospitalisedforacuteheartfailure:clinical implications and prognostic significance,”